Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody. Sulea T, Baardsnes J, Stuible M, Rohani N, et al. PLoS One 2022;17:e0266250.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sulea T, Baardsnes J, Stuible M, Rohani N, et al. Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody. PLoS One 2022;17:e0266250.
PMID: 35353868